This company seems to have been delisted
Reason: Acquired by Amgen
Last recorded trade on: November 25, 2022
Source: https://www.amgen.com/newsroom/press-releases/2022/08/amgen-to-acquire-chemocentryx-for-$4-billion-in-cash
Reason: Acquired by Amgen
Last recorded trade on: November 25, 2022
Source: https://www.amgen.com/newsroom/press-releases/2022/08/amgen-to-acquire-chemocentryx-for-$4-billion-in-cash
ChemoCentryx
CCXI
47,50 €
Share price
0.00%
Change (1 day)
32.54%
Change (1 year)
Categories
Market capitalization of ChemoCentryx (CCXI)
Last known market cap: €3.41 Billion
On November 25, 2022 ChemoCentryx had a market cap of €3.41 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of ChemoCentryx from 2012 to 2022
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2022 | €3.48 B | 54.82% |
| 2021 | €2.25 B | -35.38% |
| 2020 | €3.48 B | 63.83% |
| 2019 | €2.12 B | 340.24% |
| 2018 | €0.48 B | 99.75% |
| 2017 | €0.24 B | -28.1% |
| 2016 | €0.33 B | 2.75% |
| 2015 | €0.32 B | 34.16% |
| 2014 | €0.24 B | 35.69% |
| 2013 | €0.17 B | -40.2% |
| 2012 | €0.30 B |
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 | €16.11 B | 371.80% | 🇺🇸 USA |
 | €299.55 B | 8,668.01% | 🇺🇸 USA |
 | €67.62 B | 1,879.37% | 🇬🇧 UK |
 | €101.95 B | 2,884.30% | 🇺🇸 USA |
 | €331.69 B | 9,608.74% | 🇺🇸 USA |
 | €143.59 B | 4,102.98% | 🇺🇸 USA |
 | €117.26 B | 3,332.49% | 🇺🇸 USA |
 | €16.05 B | 370.08% | 🇮🇱 Israel |
 | €187.36 B | 5,384.14% | 🇺🇸 USA |